This is our first look at Covid vaccines rolling off the production line in the hope of ending the pandemic that has shaken the world in 2020.
US drug giant Pfizer has revealed it has already manufactured “several hundred thousand doses” which are undergoing clinical trials.
The company works with German biotechnology firm BioNTech and aims to create 100 million doses by this year, of which a whopping 40 million are destined for the UK.
By 2021, the company aims to manufacture 1.3billion jabs.
Every patient who receives the vaccine will need two doses.
Video released by Pfizer shows thousands of bottles of vials rolling in its manufacturing plant in Puurs, Belgium.
The non-stop production line goes seamlessly from filling up the jab to the packaging.
Last week, Pfizer said it plans to apply for emergency US approval of its vaccine in November and is now running a trial on 44,000 people.
In an interview with Mail on Sunday, the company’s UK boss Ben Osborn said: “It was great to see the first vial coming off the manufacturing line.
“It just brought a tremendous smile to my face to see all of this work actually result in a product.”
The news came just as it was reported that the NHS is preparing to introduce a coronavirus vaccine soon after Christmas.
Jonathan Van-Tam, UK’s deputy chief medical officer, said stage three of the vaccine created at Oxford University, which is being produced by Astra Zeneca, could be rolled-out in December.
He said in a briefing to MPs on Monday: “We aren’t light years away from it.
“It isn’t a totally unrealistic suggestion that we could deploy a vaccine soon after Christmas.
“That would have a significant impact on hospital admissions and deaths.”